Endocrine Testing Market Report by Test Type, Technology, End Use, and Region 2025-2033
상품코드:1800868
리서치사:IMARC
발행일:2025년 08월
페이지 정보:영문 138 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계 내분비 검사 시장 규모는 2024년 120억 달러에 달했습니다. 향후 IMARC Group은 이 시장이 2033년까지 211억 달러에 달할 것으로 예상하며, 2025년부터 2033년까지 6.53%의 연평균 성장률(CAGR)을 기록할 것으로 전망하고 있습니다.
내분비 검사는 체내 호르몬 수치를 측정하고 호르몬 관련 질환을 진단하기 위해 시행하는 의료 시술을 말합니다. 이 검사는 특정 만성질환의 발병으로 이어질 수 있는 호르몬 농도의 불균형을 감지하는 데 도움이 됩니다. 이러한 질환은 보통 세침흡인(FNA), 초음파 검사, 컴퓨터 단층촬영(CT), 자기공명영상(MRI), 양전자방출검사(PET), 방사성 요오드 스캔(RAI), 정맥 샘플링 등을 통해 검사합니다. 이렇게 얻은 검사 결과는 질병의 진행을 판단하고 환자에게 제공되는 치료의 효과를 모니터링하는 데 도움이 됩니다.
부신기능부전, 쿠싱병, 거대증, 갑상선기능저하증, 갑상선기능항진증 등 내분비 관련 질환의 유병률 증가는 시장 성장을 촉진하는 중요한 요인 중 하나입니다. 또한, 적시 검사의 이점에 대한 건강 인식과 인식이 높아짐에 따라 시장 성장을 촉진하고 있습니다. 정기적인 검사는 특히 노년층에서 합병증 발생과 질병 악화의 위험을 최소화합니다. 이에 따라 노인 인구의 증가가 또 다른 주요 성장 촉진요인으로 작용하고 있습니다. 또한, 코로나 바이러스(COVID-19)의 유행으로 인해 내분비 검사는 감염된 환자의 고혈당을 감지하기 위해 널리 사용되고 있습니다. 또한, 바이오센서를 탑재한 조작이 간편한 혁신적인 검사 키트의 개발로 사용자 친화적이고 비용 효율적인 재택 진단이 가능해져 시장 전망이 밝아지고 있습니다. 헬스케어 센터, 검사실, 진단 센터에서는 높은 정확도와 정확한 결과를 제공하기 위해 기술적으로 진보된 질량 분석이 가능한 액체 크로마토그래피(LC-MS) 기술도 사용되고 있습니다. 헬스케어 인프라 개선 등 다른 요인들도 시장을 더욱 견인할 것으로 예상됩니다.
본 보고서에서 다루는 주요 질문
세계 내분비 검사 시장은 지금까지 어떻게 성장해 왔으며, 향후 몇 년 동안 어떻게 성장할 것인가?
The global endocrine testing market size reached USD 12.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 21.1 Billion by 2033, exhibiting a growth rate (CAGR) of 6.53% during 2025-2033.
Endocrine testing refers to the medical procedures conducted to measure the hormonal levels in the body and the diagnosis of hormone-related disorders. The testing aids in detecting an imbalance in the concentrations of hormones that may lead to the development of certain chronic conditions. These disorders are usually tested by fine-needle aspiration (FNA), ultrasound, computerized tomography (CT), magnetic resonance imaging (MRI), positron emission test (PET), radioactive iodine scan (RAI) and venous sampling. The test results thus obtained can assist in determining the progression of the disorder and monitoring the effects of the treatment being provided to the patient.
The increasing prevalence of endocrine-related disorders, such as adrenal insufficiency, Cushing's disease, gigantism, hypothyroidism and hyperthyroidism, represents one of the key factors driving the growth of the market. Furthermore, the increasing health consciousness and awareness regarding the benefits of timely testing is providing a boost to the market growth. Periodic testing minimizes the risks of developing complications or aggravation of the disorder, especially in elderly patients. In line with this, the rising geriatric population is acting as another major growth-inducing factor. Moreover, due to the onset of the coronavirus (COVID-19) pandemic, endocrine testing is being widely used to detect hyperglycemia in infected patients. Additionally, the development of innovative easy-to-operate test kits equipped with biosensors that facilitate user-friendly and cost-effective home-based diagnosis is creating a positive outlook for the market. Healthcare centers, laboratories and diagnostic centers are also using technologically advanced liquid chromatography with mass spectrometry (LC-MS) techniques to provide highly precise and accurate results. Other factors, including improvements in the healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
Breakup by Test Type:
Thyroid Test
Insulin Test
Human Chorionic Gonadotropin Test
Prolactin Test
Luteinizing Hormone Test
Progesterone Test
Others
Breakup by Technology:
Immunoassay
Tandem Mass Spectroscopy
Sensor Technology
LC-MS
Others
Breakup by End Use:
Hospitals
Ambulatory Care Centers
Clinical Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioMerieux SA, DiaSorin S.p.A., F. Hoffmann-La Roche AG (Roche Holding AG), Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens Aktiengesellschaft) and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global endocrine testing market performed so far and how will it perform in the coming years ?
What has been the impact of COVID-19 on the global endocrine testing market ?
What are the key regional markets ?
What is the breakup of the market based on the test type ?
What is the breakup of the market based on the technology ?
What is the breakup of the market based on the end use ?
What are the various stages in the value chain of the industry ?
What are the key driving factors and challenges in the industry ?
What is the structure of the global endocrine testing market and who are the key players ?
What is the degree of competition in the industry ?
Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Endocrine Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Test Type
6.1 Thyroid Test
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Insulin Test
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Human Chorionic Gonadotropin Test
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Prolactin Test
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Luteinizing Hormone Test
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Progesterone Test
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Technology
7.1 Immunoassay
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Tandem Mass Spectroscopy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Sensor Technology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 LC-MS
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End Use
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Care Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Clinical Laboratories
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Agilent Technologies Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bio-Rad Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 BioMerieux SA
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 DiaSorin S.p.A.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche AG (Roche Holding AG)
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.7 Laboratory Corporation of America Holdings
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Quest Diagnostics Incorporated
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Siemens Healthineers AG (Siemens Aktiengesellschaft)
